Literature DB >> 18217977

Long-term adjustment of early-stage ovarian cancer survivors.

U A Matulonis1, A Kornblith, H Lee, J Bryan, C Gibson, C Wells, J Lee, L Sullivan, R Penson.   

Abstract

The objectives of this study were to describe the quality of life (QOL), consequences of treatment, complementary therapy use, and factors correlating with psychologic state in 58 survivors of early-stage ovarian cancer since little is known about the QOL of early-stage ovarian cancer survivors. Survivors were interviewed using standardized measures to assess physical, psychologic, social, and sexual functioning; impact of cancer on socioeconomic status; and complementary therapy use. Survivors reported good physical QOL scores and few unmet needs. However, menopausal symptoms and negative impact on sexuality were reported. Less than 10% of survivors reported either an interest in sex or were sexually active. Psychologic assessment yielded a subset of 26% of patients with scores suggestive of posttraumatic stress disorder (PTSD) and 40% of survivors scored below the norm on the Mental Health Inventory-17 Survey. One third of patients required treatment for family/personal problems and took antianxiety medications. About 56% of survivors reported fear of cancer recurrence and 59% reported anxiety when their CA125 is tested. Better mental health was significantly related to less fatigue (Functional Assessment of Cancer Therapy [FACT]-fatigue, r = 0.61, P < 0.0001), less pain (European Organisation for Research and Treatment of Cancer [EORTC], r =-0.54, P < 0.0001), fewer stressful life events (Life Event Scale, r =-0.44, P > 0.001), and greater social support (MOS Social Support Survey, r = 0.41, P < 0.01). Early-stage ovarian cancer survivors had few physical complaints and unmet needs, but psychologic distress was evident in a subset of survivors; the majority of survivors reported sexual dysfunction. These results indicate the need for intervention and improved distress screening in the early-stage ovarian cancer population.

Entities:  

Mesh:

Year:  2008        PMID: 18217977     DOI: 10.1111/j.1525-1438.2007.01167.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  43 in total

Review 1.  Health-related quality of life in ovarian cancer patients and its impact on clinical management.

Authors:  Dana M Chase; Lari Wenzel
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-08       Impact factor: 2.217

Review 2.  A systematic review of ovarian cancer and fear of recurrence.

Authors:  Melissa Ozga; Carol Aghajanian; Shannon Myers-Virtue; Glynnis McDonnell; Sabrina Jhanwar; Shira Hichenberg; Isabel Sulimanoff
Journal:  Palliat Support Care       Date:  2015-03-02

Review 3.  Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

Authors:  Sébastien Simard; Belinda Thewes; Gerry Humphris; Mélanie Dixon; Ceara Hayden; Shab Mireskandari; Gozde Ozakinci
Journal:  J Cancer Surviv       Date:  2013-03-10       Impact factor: 4.442

4.  Faith and mental health in an oncology population.

Authors:  Janice Bell Meisenhelder; Nancy J Schaeffer; Jerry Younger; Marisa Lauria
Journal:  J Relig Health       Date:  2013-06

5.  Psychological Problems Experienced by Women with Gynecological Cancer and How They Cope with It: A Phenomenological Study in Turkey.

Authors:  Sengül Yaman; Sultan Ayaz
Journal:  Health Soc Work       Date:  2016-08-01

Review 6.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

Review 7.  Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.

Authors:  Dana M Chase; Steven J Gibson; Daniele A Sumner; Jennifer W Bea; David S Alberts
Journal:  Curr Treat Options Oncol       Date:  2014-03

8.  Distress Screening: Evaluating a Protocol for Gynecologic Cancer Survivors
.

Authors:  Cynae Johnson; Marshalee George; Amanda N Fader
Journal:  Clin J Oncol Nurs       Date:  2017-06-01       Impact factor: 1.027

9.  Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study.

Authors:  Jeanne Carter; Helen Huang; Dana M Chase; Joan L Walker; David Cella; Lari Wenzel
Journal:  Int J Gynecol Cancer       Date:  2012-11       Impact factor: 3.437

Review 10.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.